Vesalius Biocapital offers venture capital
to young European innovative life science companies

logo
Portfolio News

GenKyoTex

GenKyoTex is a product-driven biopharmaceutical company dedicated to the development of innovative therapeutics blocking the source of production of oxygen radicals in a specific manner to meet unmet medical need.
IPO on Euronext

http://www.genkyotex.com

Therapeutics

Switzerland / France

Investing phase